P55746 AF NFT

Cytotoxicity-associated immunodominant antigen

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeibxiljlr263k72xbgxd4a2f74xlpmdtwomu5ok3zuuxaxwl3topym/metadata.json
IPFS of structure file: 
bafybeidnfkr266b73czymywjtxdoj66ry2ijl4a7ysomrggtplkf3v6gbu/AF-P55746-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xdF2b063d4B94F3f46D117B1af99A846bD4a59284
First NFT owner address (bech32): 
genesis1mu4sv02tjnelgmg30vd0nx5yd022ty5y7akg2m
Current NFT ID #59081 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
59081
Accession (UniProt):
P55746
Name::
Cytotoxicity-associated immunodominant antigen
Experimental Method:
Predicted structure
Sequence source:
HELICOBACTER PYLORI

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P55746 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P55746|CGA2_HELPX Cytotoxicity-associated immunodominant antigen OS=Helicobacter pylori OX=210 GN=cagA PE=4 SV=1 MTNETIDQQPQTEAAFNPQQFINNLQVAFLKVDNAVASYDPDQKPIVDKNDRDNRQAFEGISQLREEYSNKAIKNPTKKNQYFSDFINKSNDLINKDNLIVVESSTKSFQKFGDQRYRIFTSWVSHQNDPSKINTRCIRNFMEHTIQPPIPDDKEKAEFLKSAKQSFAGIIIGNQIRTDQKFMGVFDESLKERQEAEKNGGPTGGDWLDIFLSFIFDKKQSSDVKEAINQEPLPHVQPDIATSTTHIQGLPPESRDLLDERGNFSKFTLGDMEMLDVEGVADMDPNYKFNQLLIHNNTLSSVLMGSHDGIEPEKVSLLYAGNGGFGAKHDWNATVGYKDQQGNNVATIINVHMKNGSGLVIAGGEKGINNPSFYLYKEDQLTGSQRALSQEEIQNKIDFMEFLAQNNAKLDSLSEKEKEKFRNEIKDFQKDSKPYLDALGNDRIAFVSKKDPKHSALITEFNKGDLSYTLKVMGKKQIKALDREKNVTLQGNLKHDGVMFVNYSNFKYTNASKSPNKGVGVTNGVSHLEAGFSKVAVFNLPNLNNLAITSVVRRDLEDKLIAKGLSPQEANKLVKDFLSSNKELVGKALNFNKAVAEAKNTGNYDEVKRAQKDLEKSLKKREHLEKGDVAKNLESKSGNKNKMEAKAQANSQKDEIFALINKEANRDARAIAYAQNLKGIKRELSDKLENINKDLKDFSKSFDGFKNGKNKDFSKAEETLKALKGSVKDLGINPEWISKVENLNAALNEFKNGKNKDFSKVTQAKSDQENSIKDVIINQKITDKVDELNQAVSVAKIACDFSGVEQALADLKNFSKEQLAQQAQKNESFNVGKSEIYQSVKNGVNGTLVGNGLSGIEATALAKNFSDIKKELNEKFKNFNNNNNNGLKNGGEPIYAQVNKKKTGQVASPEEPIYAQVAKKVTKKIDQLNQAATSGFGGVGQAGFPLKRHDKVEDLSKVGRSVSPEPIYATIDDLGGSFPLKRHDKVDDLSKVGLSRNQELTQKIDNLSQAVSEAKAGFFGNLEQTIDKLKDFTKNNPVNLWAESAKKVPASLSAKLDNYATNSHTRINSNIQNGAINEKATGTERQKNPEWLKLVNDKIVAHNVGSVPLSEYDNIGFSQKNMKDYSDSFKFSTKLNNAVKDIKSGFTQFLANAFSTGYYSMARENAEHGIKNANTKGGFQKS